Optimizing Clinical Trials Across the Therapeutic Spectrum
Koneksa’s science-focused team, multi-device integration capabilities, leading-edge SaaS platform, and end-to-end services can help streamline clinical trials in any therapeutic area. While we have deep experience in Parkinson’s disease and other neurology, oncology, and respiratory disease research areas, our experience goes well beyond that:
- Atopic dermatitis
- Diabetes
- Disturbed sleep
- Hemophilia
- Immunology
- Liver disease
- Multiple sclerosis
- Organ transplant rejection
The research potential created by remotely obtained digital biomarkers is virtually limitless, and Koneksa is continuously exploring new ways to apply our technologies and experience to accelerate clinical trials and reduce patient burden.
The Measures That Matter — for Any Trial
Koneksa’s remote multilingual solutions are suited to trials anywhere around the globe, as well as for difficult-to-access patients. The removal of geographical barriers is just the beginning, however; not only are our solutions borderless, but they also leverage continuous collection capabilities and real-time patient data cloud transfer to deliver better data in less time.
In-clinic measures aren’t enough to paint an accurate picture of the effects of a treatment: They are too infrequent and prone to variability.
Densely acquired, ecologically valid measures that speed trials and reduce sample size are the solution. This is what Koneksa can do for you.
Anytime. Anywhere. Any Trial.
No matter what therapeutic area your trial is in, validated digital biomarkers can add tremendous value for you and for patients. That is why Koneksa was founded.